Medical Care
Global Cell Theraputics Market Research Report 2025
- Jul 08, 25
- ID: 349126
- Pages: 104
- Figures: 102
- Views: 11
The global market for Cell Theraputics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cell theraputics are therapies in which cellular material is injected, grafted or implanted into a patient, mostly intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
North American market for Cell Theraputics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Theraputics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Theraputics in Allogeneic Cell Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Theraputics include Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Cti Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Theraputics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Theraputics.
The Cell Theraputics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Theraputics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Theraputics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb Company (Celgene)
Bluebird Bio
Crispr Therapeutics
Roche (Spark Therapeutics)
PTC Therapeutics
Moderna Therapeutics
Quanterix
Brainstorm Cell Therapeutics Inc.
Lineage Cell Therapeutics
Cti Biopharma
Atara Biotherapeutics, Inc
Adaptimmune
Novartis
Gilead Sciences
Juno Therapeutics
Takeda Pharmaceuticals
Celgene
Adaptimmune Therapeutics
CARsgen Therapeutics
Precision Biosciences
Sangamo Therapeutics
Segment by Type
Stem Cells
Immunocyte
Segment by Application
Allogeneic Cell Therapy
Autologous Cell Therapy
Xenogeneic Cell Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Theraputics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cell theraputics are therapies in which cellular material is injected, grafted or implanted into a patient, mostly intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
North American market for Cell Theraputics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Theraputics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Theraputics in Allogeneic Cell Therapy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Theraputics include Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Cti Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Theraputics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Theraputics.
The Cell Theraputics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Theraputics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Theraputics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb Company (Celgene)
Bluebird Bio
Crispr Therapeutics
Roche (Spark Therapeutics)
PTC Therapeutics
Moderna Therapeutics
Quanterix
Brainstorm Cell Therapeutics Inc.
Lineage Cell Therapeutics
Cti Biopharma
Atara Biotherapeutics, Inc
Adaptimmune
Novartis
Gilead Sciences
Juno Therapeutics
Takeda Pharmaceuticals
Celgene
Adaptimmune Therapeutics
CARsgen Therapeutics
Precision Biosciences
Sangamo Therapeutics
Segment by Type
Stem Cells
Immunocyte
Segment by Application
Allogeneic Cell Therapy
Autologous Cell Therapy
Xenogeneic Cell Therapy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Theraputics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Theraputics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cells
1.2.3 Immunocyte
1.3 Market by Application
1.3.1 Global Cell Theraputics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Allogeneic Cell Therapy
1.3.3 Autologous Cell Therapy
1.3.4 Xenogeneic Cell Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Theraputics Market Perspective (2020-2031)
2.2 Global Cell Theraputics Growth Trends by Region
2.2.1 Global Cell Theraputics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Theraputics Historic Market Size by Region (2020-2025)
2.2.3 Cell Theraputics Forecasted Market Size by Region (2026-2031)
2.3 Cell Theraputics Market Dynamics
2.3.1 Cell Theraputics Industry Trends
2.3.2 Cell Theraputics Market Drivers
2.3.3 Cell Theraputics Market Challenges
2.3.4 Cell Theraputics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Theraputics Players by Revenue
3.1.1 Global Top Cell Theraputics Players by Revenue (2020-2025)
3.1.2 Global Cell Theraputics Revenue Market Share by Players (2020-2025)
3.2 Global Cell Theraputics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Theraputics Revenue
3.4 Global Cell Theraputics Market Concentration Ratio
3.4.1 Global Cell Theraputics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Theraputics Revenue in 2024
3.5 Global Key Players of Cell Theraputics Head office and Area Served
3.6 Global Key Players of Cell Theraputics, Product and Application
3.7 Global Key Players of Cell Theraputics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Theraputics Breakdown Data by Type
4.1 Global Cell Theraputics Historic Market Size by Type (2020-2025)
4.2 Global Cell Theraputics Forecasted Market Size by Type (2026-2031)
5 Cell Theraputics Breakdown Data by Application
5.1 Global Cell Theraputics Historic Market Size by Application (2020-2025)
5.2 Global Cell Theraputics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Theraputics Market Size (2020-2031)
6.2 North America Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Theraputics Market Size by Country (2020-2025)
6.4 North America Cell Theraputics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Theraputics Market Size (2020-2031)
7.2 Europe Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Theraputics Market Size by Country (2020-2025)
7.4 Europe Cell Theraputics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Theraputics Market Size (2020-2031)
8.2 Asia-Pacific Cell Theraputics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Theraputics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Theraputics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Theraputics Market Size (2020-2031)
9.2 Latin America Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Theraputics Market Size by Country (2020-2025)
9.4 Latin America Cell Theraputics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Theraputics Market Size (2020-2031)
10.2 Middle East & Africa Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Theraputics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Theraputics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company (Celgene)
11.1.1 Bristol-Myers Squibb Company (Celgene) Company Details
11.1.2 Bristol-Myers Squibb Company (Celgene) Business Overview
11.1.3 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Introduction
11.1.4 Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2020-2025)
11.1.5 Bristol-Myers Squibb Company (Celgene) Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio Cell Theraputics Introduction
11.2.4 Bluebird Bio Revenue in Cell Theraputics Business (2020-2025)
11.2.5 Bluebird Bio Recent Development
11.3 Crispr Therapeutics
11.3.1 Crispr Therapeutics Company Details
11.3.2 Crispr Therapeutics Business Overview
11.3.3 Crispr Therapeutics Cell Theraputics Introduction
11.3.4 Crispr Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.3.5 Crispr Therapeutics Recent Development
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Details
11.4.2 Roche (Spark Therapeutics) Business Overview
11.4.3 Roche (Spark Therapeutics) Cell Theraputics Introduction
11.4.4 Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2020-2025)
11.4.5 Roche (Spark Therapeutics) Recent Development
11.5 PTC Therapeutics
11.5.1 PTC Therapeutics Company Details
11.5.2 PTC Therapeutics Business Overview
11.5.3 PTC Therapeutics Cell Theraputics Introduction
11.5.4 PTC Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.5.5 PTC Therapeutics Recent Development
11.6 Moderna Therapeutics
11.6.1 Moderna Therapeutics Company Details
11.6.2 Moderna Therapeutics Business Overview
11.6.3 Moderna Therapeutics Cell Theraputics Introduction
11.6.4 Moderna Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.6.5 Moderna Therapeutics Recent Development
11.7 Quanterix
11.7.1 Quanterix Company Details
11.7.2 Quanterix Business Overview
11.7.3 Quanterix Cell Theraputics Introduction
11.7.4 Quanterix Revenue in Cell Theraputics Business (2020-2025)
11.7.5 Quanterix Recent Development
11.8 Brainstorm Cell Therapeutics Inc.
11.8.1 Brainstorm Cell Therapeutics Inc. Company Details
11.8.2 Brainstorm Cell Therapeutics Inc. Business Overview
11.8.3 Brainstorm Cell Therapeutics Inc. Cell Theraputics Introduction
11.8.4 Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2020-2025)
11.8.5 Brainstorm Cell Therapeutics Inc. Recent Development
11.9 Lineage Cell Therapeutics
11.9.1 Lineage Cell Therapeutics Company Details
11.9.2 Lineage Cell Therapeutics Business Overview
11.9.3 Lineage Cell Therapeutics Cell Theraputics Introduction
11.9.4 Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.9.5 Lineage Cell Therapeutics Recent Development
11.10 Cti Biopharma
11.10.1 Cti Biopharma Company Details
11.10.2 Cti Biopharma Business Overview
11.10.3 Cti Biopharma Cell Theraputics Introduction
11.10.4 Cti Biopharma Revenue in Cell Theraputics Business (2020-2025)
11.10.5 Cti Biopharma Recent Development
11.11 Atara Biotherapeutics, Inc
11.11.1 Atara Biotherapeutics, Inc Company Details
11.11.2 Atara Biotherapeutics, Inc Business Overview
11.11.3 Atara Biotherapeutics, Inc Cell Theraputics Introduction
11.11.4 Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2020-2025)
11.11.5 Atara Biotherapeutics, Inc Recent Development
11.12 Adaptimmune
11.12.1 Adaptimmune Company Details
11.12.2 Adaptimmune Business Overview
11.12.3 Adaptimmune Cell Theraputics Introduction
11.12.4 Adaptimmune Revenue in Cell Theraputics Business (2020-2025)
11.12.5 Adaptimmune Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Cell Theraputics Introduction
11.13.4 Novartis Revenue in Cell Theraputics Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Cell Theraputics Introduction
11.14.4 Gilead Sciences Revenue in Cell Theraputics Business (2020-2025)
11.14.5 Gilead Sciences Recent Development
11.15 Juno Therapeutics
11.15.1 Juno Therapeutics Company Details
11.15.2 Juno Therapeutics Business Overview
11.15.3 Juno Therapeutics Cell Theraputics Introduction
11.15.4 Juno Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.15.5 Juno Therapeutics Recent Development
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Details
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Cell Theraputics Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2020-2025)
11.16.5 Takeda Pharmaceuticals Recent Development
11.17 Celgene
11.17.1 Celgene Company Details
11.17.2 Celgene Business Overview
11.17.3 Celgene Cell Theraputics Introduction
11.17.4 Celgene Revenue in Cell Theraputics Business (2020-2025)
11.17.5 Celgene Recent Development
11.18 Adaptimmune Therapeutics
11.18.1 Adaptimmune Therapeutics Company Details
11.18.2 Adaptimmune Therapeutics Business Overview
11.18.3 Adaptimmune Therapeutics Cell Theraputics Introduction
11.18.4 Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.18.5 Adaptimmune Therapeutics Recent Development
11.19 CARsgen Therapeutics
11.19.1 CARsgen Therapeutics Company Details
11.19.2 CARsgen Therapeutics Business Overview
11.19.3 CARsgen Therapeutics Cell Theraputics Introduction
11.19.4 CARsgen Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.19.5 CARsgen Therapeutics Recent Development
11.20 Precision Biosciences
11.20.1 Precision Biosciences Company Details
11.20.2 Precision Biosciences Business Overview
11.20.3 Precision Biosciences Cell Theraputics Introduction
11.20.4 Precision Biosciences Revenue in Cell Theraputics Business (2020-2025)
11.20.5 Precision Biosciences Recent Development
11.21 Sangamo Therapeutics
11.21.1 Sangamo Therapeutics Company Details
11.21.2 Sangamo Therapeutics Business Overview
11.21.3 Sangamo Therapeutics Cell Theraputics Introduction
11.21.4 Sangamo Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.21.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Theraputics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cells
1.2.3 Immunocyte
1.3 Market by Application
1.3.1 Global Cell Theraputics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Allogeneic Cell Therapy
1.3.3 Autologous Cell Therapy
1.3.4 Xenogeneic Cell Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Theraputics Market Perspective (2020-2031)
2.2 Global Cell Theraputics Growth Trends by Region
2.2.1 Global Cell Theraputics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Theraputics Historic Market Size by Region (2020-2025)
2.2.3 Cell Theraputics Forecasted Market Size by Region (2026-2031)
2.3 Cell Theraputics Market Dynamics
2.3.1 Cell Theraputics Industry Trends
2.3.2 Cell Theraputics Market Drivers
2.3.3 Cell Theraputics Market Challenges
2.3.4 Cell Theraputics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Theraputics Players by Revenue
3.1.1 Global Top Cell Theraputics Players by Revenue (2020-2025)
3.1.2 Global Cell Theraputics Revenue Market Share by Players (2020-2025)
3.2 Global Cell Theraputics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Theraputics Revenue
3.4 Global Cell Theraputics Market Concentration Ratio
3.4.1 Global Cell Theraputics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Theraputics Revenue in 2024
3.5 Global Key Players of Cell Theraputics Head office and Area Served
3.6 Global Key Players of Cell Theraputics, Product and Application
3.7 Global Key Players of Cell Theraputics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Theraputics Breakdown Data by Type
4.1 Global Cell Theraputics Historic Market Size by Type (2020-2025)
4.2 Global Cell Theraputics Forecasted Market Size by Type (2026-2031)
5 Cell Theraputics Breakdown Data by Application
5.1 Global Cell Theraputics Historic Market Size by Application (2020-2025)
5.2 Global Cell Theraputics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Theraputics Market Size (2020-2031)
6.2 North America Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Theraputics Market Size by Country (2020-2025)
6.4 North America Cell Theraputics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Theraputics Market Size (2020-2031)
7.2 Europe Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Theraputics Market Size by Country (2020-2025)
7.4 Europe Cell Theraputics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Theraputics Market Size (2020-2031)
8.2 Asia-Pacific Cell Theraputics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Theraputics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Theraputics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Theraputics Market Size (2020-2031)
9.2 Latin America Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Theraputics Market Size by Country (2020-2025)
9.4 Latin America Cell Theraputics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Theraputics Market Size (2020-2031)
10.2 Middle East & Africa Cell Theraputics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Theraputics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Theraputics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company (Celgene)
11.1.1 Bristol-Myers Squibb Company (Celgene) Company Details
11.1.2 Bristol-Myers Squibb Company (Celgene) Business Overview
11.1.3 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Introduction
11.1.4 Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2020-2025)
11.1.5 Bristol-Myers Squibb Company (Celgene) Recent Development
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Details
11.2.2 Bluebird Bio Business Overview
11.2.3 Bluebird Bio Cell Theraputics Introduction
11.2.4 Bluebird Bio Revenue in Cell Theraputics Business (2020-2025)
11.2.5 Bluebird Bio Recent Development
11.3 Crispr Therapeutics
11.3.1 Crispr Therapeutics Company Details
11.3.2 Crispr Therapeutics Business Overview
11.3.3 Crispr Therapeutics Cell Theraputics Introduction
11.3.4 Crispr Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.3.5 Crispr Therapeutics Recent Development
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Details
11.4.2 Roche (Spark Therapeutics) Business Overview
11.4.3 Roche (Spark Therapeutics) Cell Theraputics Introduction
11.4.4 Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2020-2025)
11.4.5 Roche (Spark Therapeutics) Recent Development
11.5 PTC Therapeutics
11.5.1 PTC Therapeutics Company Details
11.5.2 PTC Therapeutics Business Overview
11.5.3 PTC Therapeutics Cell Theraputics Introduction
11.5.4 PTC Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.5.5 PTC Therapeutics Recent Development
11.6 Moderna Therapeutics
11.6.1 Moderna Therapeutics Company Details
11.6.2 Moderna Therapeutics Business Overview
11.6.3 Moderna Therapeutics Cell Theraputics Introduction
11.6.4 Moderna Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.6.5 Moderna Therapeutics Recent Development
11.7 Quanterix
11.7.1 Quanterix Company Details
11.7.2 Quanterix Business Overview
11.7.3 Quanterix Cell Theraputics Introduction
11.7.4 Quanterix Revenue in Cell Theraputics Business (2020-2025)
11.7.5 Quanterix Recent Development
11.8 Brainstorm Cell Therapeutics Inc.
11.8.1 Brainstorm Cell Therapeutics Inc. Company Details
11.8.2 Brainstorm Cell Therapeutics Inc. Business Overview
11.8.3 Brainstorm Cell Therapeutics Inc. Cell Theraputics Introduction
11.8.4 Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2020-2025)
11.8.5 Brainstorm Cell Therapeutics Inc. Recent Development
11.9 Lineage Cell Therapeutics
11.9.1 Lineage Cell Therapeutics Company Details
11.9.2 Lineage Cell Therapeutics Business Overview
11.9.3 Lineage Cell Therapeutics Cell Theraputics Introduction
11.9.4 Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.9.5 Lineage Cell Therapeutics Recent Development
11.10 Cti Biopharma
11.10.1 Cti Biopharma Company Details
11.10.2 Cti Biopharma Business Overview
11.10.3 Cti Biopharma Cell Theraputics Introduction
11.10.4 Cti Biopharma Revenue in Cell Theraputics Business (2020-2025)
11.10.5 Cti Biopharma Recent Development
11.11 Atara Biotherapeutics, Inc
11.11.1 Atara Biotherapeutics, Inc Company Details
11.11.2 Atara Biotherapeutics, Inc Business Overview
11.11.3 Atara Biotherapeutics, Inc Cell Theraputics Introduction
11.11.4 Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2020-2025)
11.11.5 Atara Biotherapeutics, Inc Recent Development
11.12 Adaptimmune
11.12.1 Adaptimmune Company Details
11.12.2 Adaptimmune Business Overview
11.12.3 Adaptimmune Cell Theraputics Introduction
11.12.4 Adaptimmune Revenue in Cell Theraputics Business (2020-2025)
11.12.5 Adaptimmune Recent Development
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Cell Theraputics Introduction
11.13.4 Novartis Revenue in Cell Theraputics Business (2020-2025)
11.13.5 Novartis Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Cell Theraputics Introduction
11.14.4 Gilead Sciences Revenue in Cell Theraputics Business (2020-2025)
11.14.5 Gilead Sciences Recent Development
11.15 Juno Therapeutics
11.15.1 Juno Therapeutics Company Details
11.15.2 Juno Therapeutics Business Overview
11.15.3 Juno Therapeutics Cell Theraputics Introduction
11.15.4 Juno Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.15.5 Juno Therapeutics Recent Development
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Details
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Cell Theraputics Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2020-2025)
11.16.5 Takeda Pharmaceuticals Recent Development
11.17 Celgene
11.17.1 Celgene Company Details
11.17.2 Celgene Business Overview
11.17.3 Celgene Cell Theraputics Introduction
11.17.4 Celgene Revenue in Cell Theraputics Business (2020-2025)
11.17.5 Celgene Recent Development
11.18 Adaptimmune Therapeutics
11.18.1 Adaptimmune Therapeutics Company Details
11.18.2 Adaptimmune Therapeutics Business Overview
11.18.3 Adaptimmune Therapeutics Cell Theraputics Introduction
11.18.4 Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.18.5 Adaptimmune Therapeutics Recent Development
11.19 CARsgen Therapeutics
11.19.1 CARsgen Therapeutics Company Details
11.19.2 CARsgen Therapeutics Business Overview
11.19.3 CARsgen Therapeutics Cell Theraputics Introduction
11.19.4 CARsgen Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.19.5 CARsgen Therapeutics Recent Development
11.20 Precision Biosciences
11.20.1 Precision Biosciences Company Details
11.20.2 Precision Biosciences Business Overview
11.20.3 Precision Biosciences Cell Theraputics Introduction
11.20.4 Precision Biosciences Revenue in Cell Theraputics Business (2020-2025)
11.20.5 Precision Biosciences Recent Development
11.21 Sangamo Therapeutics
11.21.1 Sangamo Therapeutics Company Details
11.21.2 Sangamo Therapeutics Business Overview
11.21.3 Sangamo Therapeutics Cell Theraputics Introduction
11.21.4 Sangamo Therapeutics Revenue in Cell Theraputics Business (2020-2025)
11.21.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell Theraputics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Stem Cells
Table 3. Key Players of Immunocyte
Table 4. Global Cell Theraputics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cell Theraputics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell Theraputics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cell Theraputics Market Share by Region (2020-2025)
Table 8. Global Cell Theraputics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cell Theraputics Market Share by Region (2026-2031)
Table 10. Cell Theraputics Market Trends
Table 11. Cell Theraputics Market Drivers
Table 12. Cell Theraputics Market Challenges
Table 13. Cell Theraputics Market Restraints
Table 14. Global Cell Theraputics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cell Theraputics Market Share by Players (2020-2025)
Table 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2024)
Table 17. Ranking of Global Top Cell Theraputics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cell Theraputics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cell Theraputics, Headquarters and Area Served
Table 20. Global Key Players of Cell Theraputics, Product and Application
Table 21. Global Key Players of Cell Theraputics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Theraputics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cell Theraputics Revenue Market Share by Type (2020-2025)
Table 25. Global Cell Theraputics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cell Theraputics Revenue Market Share by Type (2026-2031)
Table 27. Global Cell Theraputics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cell Theraputics Revenue Market Share by Application (2020-2025)
Table 29. Global Cell Theraputics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cell Theraputics Revenue Market Share by Application (2026-2031)
Table 31. North America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cell Theraputics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cell Theraputics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cell Theraputics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bristol-Myers Squibb Company (Celgene) Company Details
Table 47. Bristol-Myers Squibb Company (Celgene) Business Overview
Table 48. Bristol-Myers Squibb Company (Celgene) Cell Theraputics Product
Table 49. Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 50. Bristol-Myers Squibb Company (Celgene) Recent Development
Table 51. Bluebird Bio Company Details
Table 52. Bluebird Bio Business Overview
Table 53. Bluebird Bio Cell Theraputics Product
Table 54. Bluebird Bio Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 55. Bluebird Bio Recent Development
Table 56. Crispr Therapeutics Company Details
Table 57. Crispr Therapeutics Business Overview
Table 58. Crispr Therapeutics Cell Theraputics Product
Table 59. Crispr Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 60. Crispr Therapeutics Recent Development
Table 61. Roche (Spark Therapeutics) Company Details
Table 62. Roche (Spark Therapeutics) Business Overview
Table 63. Roche (Spark Therapeutics) Cell Theraputics Product
Table 64. Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 65. Roche (Spark Therapeutics) Recent Development
Table 66. PTC Therapeutics Company Details
Table 67. PTC Therapeutics Business Overview
Table 68. PTC Therapeutics Cell Theraputics Product
Table 69. PTC Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 70. PTC Therapeutics Recent Development
Table 71. Moderna Therapeutics Company Details
Table 72. Moderna Therapeutics Business Overview
Table 73. Moderna Therapeutics Cell Theraputics Product
Table 74. Moderna Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 75. Moderna Therapeutics Recent Development
Table 76. Quanterix Company Details
Table 77. Quanterix Business Overview
Table 78. Quanterix Cell Theraputics Product
Table 79. Quanterix Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 80. Quanterix Recent Development
Table 81. Brainstorm Cell Therapeutics Inc. Company Details
Table 82. Brainstorm Cell Therapeutics Inc. Business Overview
Table 83. Brainstorm Cell Therapeutics Inc. Cell Theraputics Product
Table 84. Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 85. Brainstorm Cell Therapeutics Inc. Recent Development
Table 86. Lineage Cell Therapeutics Company Details
Table 87. Lineage Cell Therapeutics Business Overview
Table 88. Lineage Cell Therapeutics Cell Theraputics Product
Table 89. Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 90. Lineage Cell Therapeutics Recent Development
Table 91. Cti Biopharma Company Details
Table 92. Cti Biopharma Business Overview
Table 93. Cti Biopharma Cell Theraputics Product
Table 94. Cti Biopharma Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 95. Cti Biopharma Recent Development
Table 96. Atara Biotherapeutics, Inc Company Details
Table 97. Atara Biotherapeutics, Inc Business Overview
Table 98. Atara Biotherapeutics, Inc Cell Theraputics Product
Table 99. Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 100. Atara Biotherapeutics, Inc Recent Development
Table 101. Adaptimmune Company Details
Table 102. Adaptimmune Business Overview
Table 103. Adaptimmune Cell Theraputics Product
Table 104. Adaptimmune Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 105. Adaptimmune Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Cell Theraputics Product
Table 109. Novartis Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Gilead Sciences Company Details
Table 112. Gilead Sciences Business Overview
Table 113. Gilead Sciences Cell Theraputics Product
Table 114. Gilead Sciences Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 115. Gilead Sciences Recent Development
Table 116. Juno Therapeutics Company Details
Table 117. Juno Therapeutics Business Overview
Table 118. Juno Therapeutics Cell Theraputics Product
Table 119. Juno Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 120. Juno Therapeutics Recent Development
Table 121. Takeda Pharmaceuticals Company Details
Table 122. Takeda Pharmaceuticals Business Overview
Table 123. Takeda Pharmaceuticals Cell Theraputics Product
Table 124. Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 125. Takeda Pharmaceuticals Recent Development
Table 126. Celgene Company Details
Table 127. Celgene Business Overview
Table 128. Celgene Cell Theraputics Product
Table 129. Celgene Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 130. Celgene Recent Development
Table 131. Adaptimmune Therapeutics Company Details
Table 132. Adaptimmune Therapeutics Business Overview
Table 133. Adaptimmune Therapeutics Cell Theraputics Product
Table 134. Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 135. Adaptimmune Therapeutics Recent Development
Table 136. CARsgen Therapeutics Company Details
Table 137. CARsgen Therapeutics Business Overview
Table 138. CARsgen Therapeutics Cell Theraputics Product
Table 139. CARsgen Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 140. CARsgen Therapeutics Recent Development
Table 141. Precision Biosciences Company Details
Table 142. Precision Biosciences Business Overview
Table 143. Precision Biosciences Cell Theraputics Product
Table 144. Precision Biosciences Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 145. Precision Biosciences Recent Development
Table 146. Sangamo Therapeutics Company Details
Table 147. Sangamo Therapeutics Business Overview
Table 148. Sangamo Therapeutics Cell Theraputics Product
Table 149. Sangamo Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 150. Sangamo Therapeutics Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Cell Theraputics Picture
Figure 2. Global Cell Theraputics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell Theraputics Market Share by Type: 2024 VS 2031
Figure 4. Stem Cells Features
Figure 5. Immunocyte Features
Figure 6. Global Cell Theraputics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell Theraputics Market Share by Application: 2024 VS 2031
Figure 8. Allogeneic Cell Therapy Case Studies
Figure 9. Autologous Cell Therapy Case Studies
Figure 10. Xenogeneic Cell Therapy Case Studies
Figure 11. Cell Theraputics Report Years Considered
Figure 12. Global Cell Theraputics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cell Theraputics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cell Theraputics Market Share by Region: 2024 VS 2031
Figure 15. Global Cell Theraputics Market Share by Players in 2024
Figure 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cell Theraputics Revenue in 2024
Figure 18. North America Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cell Theraputics Market Share by Country (2020-2031)
Figure 20. United States Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cell Theraputics Market Share by Country (2020-2031)
Figure 24. Germany Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cell Theraputics Market Share by Region (2020-2031)
Figure 32. China Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cell Theraputics Market Share by Country (2020-2031)
Figure 40. Mexico Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cell Theraputics Market Share by Country (2020-2031)
Figure 44. Turkey Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bristol-Myers Squibb Company (Celgene) Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 48. Bluebird Bio Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 49. Crispr Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 50. Roche (Spark Therapeutics) Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 51. PTC Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 52. Moderna Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 53. Quanterix Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 54. Brainstorm Cell Therapeutics Inc. Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 55. Lineage Cell Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 56. Cti Biopharma Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 57. Atara Biotherapeutics, Inc Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 58. Adaptimmune Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 60. Gilead Sciences Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 61. Juno Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 62. Takeda Pharmaceuticals Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 63. Celgene Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 64. Adaptimmune Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 65. CARsgen Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 66. Precision Biosciences Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 67. Sangamo Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Cell Theraputics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Stem Cells
Table 3. Key Players of Immunocyte
Table 4. Global Cell Theraputics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cell Theraputics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell Theraputics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cell Theraputics Market Share by Region (2020-2025)
Table 8. Global Cell Theraputics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cell Theraputics Market Share by Region (2026-2031)
Table 10. Cell Theraputics Market Trends
Table 11. Cell Theraputics Market Drivers
Table 12. Cell Theraputics Market Challenges
Table 13. Cell Theraputics Market Restraints
Table 14. Global Cell Theraputics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cell Theraputics Market Share by Players (2020-2025)
Table 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2024)
Table 17. Ranking of Global Top Cell Theraputics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cell Theraputics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cell Theraputics, Headquarters and Area Served
Table 20. Global Key Players of Cell Theraputics, Product and Application
Table 21. Global Key Players of Cell Theraputics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Theraputics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cell Theraputics Revenue Market Share by Type (2020-2025)
Table 25. Global Cell Theraputics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cell Theraputics Revenue Market Share by Type (2026-2031)
Table 27. Global Cell Theraputics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cell Theraputics Revenue Market Share by Application (2020-2025)
Table 29. Global Cell Theraputics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cell Theraputics Revenue Market Share by Application (2026-2031)
Table 31. North America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cell Theraputics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cell Theraputics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cell Theraputics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cell Theraputics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cell Theraputics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cell Theraputics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bristol-Myers Squibb Company (Celgene) Company Details
Table 47. Bristol-Myers Squibb Company (Celgene) Business Overview
Table 48. Bristol-Myers Squibb Company (Celgene) Cell Theraputics Product
Table 49. Bristol-Myers Squibb Company (Celgene) Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 50. Bristol-Myers Squibb Company (Celgene) Recent Development
Table 51. Bluebird Bio Company Details
Table 52. Bluebird Bio Business Overview
Table 53. Bluebird Bio Cell Theraputics Product
Table 54. Bluebird Bio Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 55. Bluebird Bio Recent Development
Table 56. Crispr Therapeutics Company Details
Table 57. Crispr Therapeutics Business Overview
Table 58. Crispr Therapeutics Cell Theraputics Product
Table 59. Crispr Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 60. Crispr Therapeutics Recent Development
Table 61. Roche (Spark Therapeutics) Company Details
Table 62. Roche (Spark Therapeutics) Business Overview
Table 63. Roche (Spark Therapeutics) Cell Theraputics Product
Table 64. Roche (Spark Therapeutics) Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 65. Roche (Spark Therapeutics) Recent Development
Table 66. PTC Therapeutics Company Details
Table 67. PTC Therapeutics Business Overview
Table 68. PTC Therapeutics Cell Theraputics Product
Table 69. PTC Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 70. PTC Therapeutics Recent Development
Table 71. Moderna Therapeutics Company Details
Table 72. Moderna Therapeutics Business Overview
Table 73. Moderna Therapeutics Cell Theraputics Product
Table 74. Moderna Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 75. Moderna Therapeutics Recent Development
Table 76. Quanterix Company Details
Table 77. Quanterix Business Overview
Table 78. Quanterix Cell Theraputics Product
Table 79. Quanterix Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 80. Quanterix Recent Development
Table 81. Brainstorm Cell Therapeutics Inc. Company Details
Table 82. Brainstorm Cell Therapeutics Inc. Business Overview
Table 83. Brainstorm Cell Therapeutics Inc. Cell Theraputics Product
Table 84. Brainstorm Cell Therapeutics Inc. Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 85. Brainstorm Cell Therapeutics Inc. Recent Development
Table 86. Lineage Cell Therapeutics Company Details
Table 87. Lineage Cell Therapeutics Business Overview
Table 88. Lineage Cell Therapeutics Cell Theraputics Product
Table 89. Lineage Cell Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 90. Lineage Cell Therapeutics Recent Development
Table 91. Cti Biopharma Company Details
Table 92. Cti Biopharma Business Overview
Table 93. Cti Biopharma Cell Theraputics Product
Table 94. Cti Biopharma Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 95. Cti Biopharma Recent Development
Table 96. Atara Biotherapeutics, Inc Company Details
Table 97. Atara Biotherapeutics, Inc Business Overview
Table 98. Atara Biotherapeutics, Inc Cell Theraputics Product
Table 99. Atara Biotherapeutics, Inc Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 100. Atara Biotherapeutics, Inc Recent Development
Table 101. Adaptimmune Company Details
Table 102. Adaptimmune Business Overview
Table 103. Adaptimmune Cell Theraputics Product
Table 104. Adaptimmune Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 105. Adaptimmune Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Cell Theraputics Product
Table 109. Novartis Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Gilead Sciences Company Details
Table 112. Gilead Sciences Business Overview
Table 113. Gilead Sciences Cell Theraputics Product
Table 114. Gilead Sciences Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 115. Gilead Sciences Recent Development
Table 116. Juno Therapeutics Company Details
Table 117. Juno Therapeutics Business Overview
Table 118. Juno Therapeutics Cell Theraputics Product
Table 119. Juno Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 120. Juno Therapeutics Recent Development
Table 121. Takeda Pharmaceuticals Company Details
Table 122. Takeda Pharmaceuticals Business Overview
Table 123. Takeda Pharmaceuticals Cell Theraputics Product
Table 124. Takeda Pharmaceuticals Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 125. Takeda Pharmaceuticals Recent Development
Table 126. Celgene Company Details
Table 127. Celgene Business Overview
Table 128. Celgene Cell Theraputics Product
Table 129. Celgene Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 130. Celgene Recent Development
Table 131. Adaptimmune Therapeutics Company Details
Table 132. Adaptimmune Therapeutics Business Overview
Table 133. Adaptimmune Therapeutics Cell Theraputics Product
Table 134. Adaptimmune Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 135. Adaptimmune Therapeutics Recent Development
Table 136. CARsgen Therapeutics Company Details
Table 137. CARsgen Therapeutics Business Overview
Table 138. CARsgen Therapeutics Cell Theraputics Product
Table 139. CARsgen Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 140. CARsgen Therapeutics Recent Development
Table 141. Precision Biosciences Company Details
Table 142. Precision Biosciences Business Overview
Table 143. Precision Biosciences Cell Theraputics Product
Table 144. Precision Biosciences Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 145. Precision Biosciences Recent Development
Table 146. Sangamo Therapeutics Company Details
Table 147. Sangamo Therapeutics Business Overview
Table 148. Sangamo Therapeutics Cell Theraputics Product
Table 149. Sangamo Therapeutics Revenue in Cell Theraputics Business (2020-2025) & (US$ Million)
Table 150. Sangamo Therapeutics Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Cell Theraputics Picture
Figure 2. Global Cell Theraputics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell Theraputics Market Share by Type: 2024 VS 2031
Figure 4. Stem Cells Features
Figure 5. Immunocyte Features
Figure 6. Global Cell Theraputics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell Theraputics Market Share by Application: 2024 VS 2031
Figure 8. Allogeneic Cell Therapy Case Studies
Figure 9. Autologous Cell Therapy Case Studies
Figure 10. Xenogeneic Cell Therapy Case Studies
Figure 11. Cell Theraputics Report Years Considered
Figure 12. Global Cell Theraputics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cell Theraputics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cell Theraputics Market Share by Region: 2024 VS 2031
Figure 15. Global Cell Theraputics Market Share by Players in 2024
Figure 16. Global Top Cell Theraputics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Theraputics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cell Theraputics Revenue in 2024
Figure 18. North America Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cell Theraputics Market Share by Country (2020-2031)
Figure 20. United States Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cell Theraputics Market Share by Country (2020-2031)
Figure 24. Germany Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cell Theraputics Market Share by Region (2020-2031)
Figure 32. China Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cell Theraputics Market Share by Country (2020-2031)
Figure 40. Mexico Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cell Theraputics Market Share by Country (2020-2031)
Figure 44. Turkey Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cell Theraputics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bristol-Myers Squibb Company (Celgene) Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 48. Bluebird Bio Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 49. Crispr Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 50. Roche (Spark Therapeutics) Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 51. PTC Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 52. Moderna Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 53. Quanterix Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 54. Brainstorm Cell Therapeutics Inc. Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 55. Lineage Cell Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 56. Cti Biopharma Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 57. Atara Biotherapeutics, Inc Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 58. Adaptimmune Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 59. Novartis Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 60. Gilead Sciences Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 61. Juno Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 62. Takeda Pharmaceuticals Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 63. Celgene Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 64. Adaptimmune Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 65. CARsgen Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 66. Precision Biosciences Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 67. Sangamo Therapeutics Revenue Growth Rate in Cell Theraputics Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232